We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

64 hedge funds and large institutions have $286M invested in ProQR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

158% more capital invested

Capital invested by funds: $111M → $286M (+$175M)

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

39% more funds holding

Funds holding: 46 → 64 (+18)

33.6% more ownership

Funds ownership: 52.68% → 86.28% (+34%)

21% more call options, than puts

Call options by funds: $2.48M | Put options by funds: $2.06M

Holders
64
Holders Change
+18
Holders Change %
+39.13%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
23
Reduced
10
Closed
6
Calls
$2.48M
Puts
$2.06M
Net Calls
+$425K
Net Calls Change
+$494K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
2
DCM
Driehaus Capital Management
Illinois
+$10.9M
3
RCM
RA Capital Management
Massachusetts
+$10.8M
4
Citigroup
Citigroup
New York
+$9.63M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.78M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$5.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.73M
3
UBS Group
UBS Group
Switzerland
-$1.95M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.41M
5
Millennium Management
Millennium Management
New York
-$741K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$42.5M +$7.23M +1,414,310 +28%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$31.4M +$23.8M +4,651,517 +4,632%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$31M +$738K +144,403 +3%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$22.4M -$314K -61,519 -2%
Goldman Sachs
5
Goldman Sachs
New York
$21.9M +$110K +21,472 +0.7%
Jennison Associates
6
Jennison Associates
New York
$17.2M -$82K -16,046 -0.6%
DCM
7
Driehaus Capital Management
Illinois
$14M +$10.9M +2,123,831 New
RCM
8
RA Capital Management
Massachusetts
$14M +$10.8M +2,117,669 New
Citigroup
9
Citigroup
New York
$12.5M +$9.63M +1,885,615 New
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$10.1M +$7.78M +1,521,800 New
OM
11
Opaleye Management
Massachusetts
$8.61M +$6.66M +1,303,000 New
DCM
12
DAFNA Capital Management
California
$7.27M -$702K -137,400 -11%
JP Morgan Chase
13
JP Morgan Chase
New York
$5.85M +$1.43M +280,378 +46%
MWNA
14
Marshall Wace North America
New York
$4.71M +$3.64M +712,529 New
Deutsche Bank
15
Deutsche Bank
Germany
$4.66M +$2.68M +523,953 +290%
Fidelity International
16
Fidelity International
Bermuda
$4.35M +$1.67M +326,258 +99%
Macquarie Group
17
Macquarie Group
Australia
$4.1M +$3.17M +620,000 New
Morgan Stanley
18
Morgan Stanley
New York
$3.18M -$2.73M -533,512 -53%
KA
19
Kerrisdale Advisers
Florida
$3M – – –
PM
20
Prosight Management
Texas
$2.98M +$997K +195,165 +77%
SCM
21
Sio Capital Management
New York
$2.6M +$2.01M +392,821 New
AGA
22
Altrinsic Global Advisors
Connecticut
$2.12M +$409K +80,000 +33%
Marshall Wace
23
Marshall Wace
United Kingdom
$2.1M +$1.62M +317,705 New
CAC
24
Cowen and Company
New York
$1.89M – – –
MIM
25
Monashee Investment Management
Massachusetts
$1.65M +$1.28M +250,000 New
1
2 3

PRQR Hedge Fund Activity: Q1 2021 in Review

64 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2021, worth a combined $286M — up 158% from $111M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRQR positions and 6 closed out — a net gain of 18 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $23.8M. The largest seller was Artal Group, exiting entirely with an estimated $5.02M sold.

  • 64 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2021, up from 46 in Q4 2020.
  • Funds reported $286M of ProQR Therapeutics stock for Q1 2021, up 158% quarter-over-quarter.
  • 24 funds opened new ProQR Therapeutics positions in Q1 2021 and 6 closed out, a net change of +18 holders.
  • The largest ProQR Therapeutics buyer in Q1 2021 was Fidelity Investments, an estimated $23.8M added.
  • The largest ProQR Therapeutics seller in Q1 2021 was Artal Group, an estimated $5.02M sold.

Based on aggregated 13F filings for Q1 2021.